Tesseract Medicines

Building on the latest advancements in antibody-drug conjugates (ADCs) and covalent inhibitors, Tesseract Medicines is pioneering a novel therapeutic approach specifically targeting cancer-related specific proteins inside cells, enabling precise delivery of cytotoxic payloads, and ushering in a new era of precision medicine.